Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions

Journal of Virology

Volumn 75, Issue 11, 2001, Pages 5129-5140

  Browning, Matthew T ^a   Schmidt, Russell D ^a   Lew, Kathy A ^a   Rizvi, Tahir A ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE TRANSFER; GENETIC RECOMBINATION; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MASON PFIZER MONKEY VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETROVIRUS; SIMIAN VIRUS; VIRION; VIRUS REPLICATION;

EID: 0035026049     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.11.5129-5140.2001     Document Type: Article

References (47)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Bach, F. H., S. C. Robson, H. Winkler, C. Ferran, K. M. Stuhlmeier, C. M. Wrighton, and W. W. Hancock. 1995. Barriers to xenotransplantation. Nat. Med. 1:869-873.
3. Bachmann, M. H., C. Mathiason-Dubard, G. H. Learn, A. G. Rodrigo, D. L. Sodora, P. Mazzetti, E. A. Hoover, and J. I. Mullins. 1997. Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades. J. Virol. 71:4241-4253.
4. Bray, M., S. Prasad, J. W. Dubay, E. Hunter, K.-T. Jeang, D. Rekosh, and M. J. Hammarskjold. 1994. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. USA 4:1256-1260.
5. Bukovsky, A. A., J. Song, and L. Naldini. 1999. Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells. J. Virol. 73:7087-7092.
6. Certo, J. L., B. F. Shook, P. D. Yin, J. T. Snider, and W.-S. Hu. 1998. Nonreciprocal pseudotyping: murine leukemia virus proteins cannot efficiently package spleen necrosis virus-based vector RNA. J. Virol. 72:5408-5413.
7. de Parseval, A., and J. H. Elder. 1999. Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Ta1) protein and characterization of a unique gene product with partial Rev activity. J. Virol. 73:608-617.
8. Elder, J. H., and T. R. Phillips. 1993. Molecular properties of feline immunodeficiency virus (FIV). Infect. Agents Dis. 2:361-374.
9. Embertson, J. E., and H. M. Temin. 1987. Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line. J. Virol. 61:2675-2683.
10. Ho, W.-Z., J. M. Harouse, K. F. Rando, E. Gonczol, A. Srinivasan, and S. A. Plotkin. 1990. Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. J. Gen. Virol. 71:97-103.
11. Ikeda, Y., K. Tomonaga, Y. Kawaguchi, M. Komoto, Y. Inoshima, Y. Tohya, T. Miyazawa, C. Kai, and T. Mikami. 1996. Feline immunodeficiency virus can infect a human cell line (MOLT-4) but establishes a state of latency in the cells. J. Gen. Virol. 77:1623-1630.
12. Johnston, J., and C. Power. 1999. Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development. J. Virol. 73:2491-2498.
13. Johnston, J. C., M. Gasmi, L. E. Lim, E. Leland, J. H. Elder, J.-K. Yee, D. J. Jolly, K. P. Campbell, B. L. Davidson, and S. Sauter. 1999. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol. 73:4991-5000.
14. Kaye, J. F., and A. M. L. Lever. 1999. Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation. J. Virol. 73:3023-3031.
15. Kaye, J. F., and A. M. L. Lever. 1998. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation. J. Virol. 72:5877-5885.
16. Kestler, H. W., III, T. Kodama, D. Ringler, M. Marthas, N. Pedersen, A. Lackner, D. Regier, P. Sehgal, M. Daniel, N. King, and R. C. Desrosiers. 1990. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109-1112.
17. Kim, Y., and R. Risser. 1993. TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the tat protein. J. Virol. 67:239-248.
18. Lutz, H. 1990. Feline retroviruses: a brief review. Vet. Microbiol. 23:131-146.
19. Marthas, M. L., B. Banapour, S. Sutjipto, M. E. Siegel, P. A. Marx, M. B. Gardner, N. C. Pedersen, and P. A. Luciw. 1989. Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J. Med. Primatol. 18:311-319.
20. Masuda, T., M. J. Kuroda, and S. Harada. 1998. Specific and independent recognition of U3 and U5 att sites by human immunodeficiency virus type 1 integrase in vivo. J. Virol. 72:8396-8402.
21. McCann, E. M., and A. M. Lever. 1997. Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2. J. Virol. 71:4133-4137.
22. Miller, R. J., S. Cairns, S. Bridges, and N. Sarver. 2000. Human immunodeficiency virus and AIDS: insights from animal lentiviruses. J. Virol. 74: 7187-7195.
23. Miyazawa, T., Y. Kawaguchi, M. Kohmoto, K. Tomonaga, and T. Mikami. 1994. Comparative functional analysis of the various lentivirus long terminal repeats in human colon carcinoma cell line (SW 480 cells) and feline renal cell line (CRFK cells). J. Vet. Med. Sci. 56:895-899.
24. Miyazawa, T., Y. Kawaguchi, M. Kohmoto, J. Sakuragi, A. Adachi, M. Fukasawa, and T. Mikami. 1992. Production of feline immunodeficiency virus in feline and non-feline non-lymphoid cell lines by transfection of an infectious molecular clone. J. Gen. Virol. 73:1543-1546.
25. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
26. Naldini, L., and I. M. Verma. 1999. Lentiviral vectors, p. 47-60. In T. Friedmann (ed.), The development of human gene therapy. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
27. Olmsted, R. A., A. K. Barnes, J. K. Yamamoto, V. M. Hirsch, R. H. Purcell, and P. R. Johnson. 1989. Molecular cloning of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86:2448-2452.
28. Olmsted, R. A., R. Langley, M. E. Roelke, R. M. Goeken, D. Adger-Johnson, J. P. Goff, J. P. Albert, C. Packer, M. K. Laurenson, T. M. Caro, et al. 1992. Worldwide prevalence of lentivirus infection in wild feline species: epidemiologic and phylogenetic aspects. J. Virol. 66:6008-6018.
29. Pedersen, N. C. 1993. The feline immunodeficiency virus, p. 181-228. In J. A. Levy (ed.), The Retroviridae, vol. 2. Plenum Press, New York, N.Y.
30. Poeschla, E. M., F. Wong-Staal, and D. J. Looney. 1998. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4:354-357.
31. Rizvi, T. A., and A. Panganiban. 1993. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J. Virol. 67:2681-2688.
32. Rizvi, T. A., R. D. Schmidt, K. A. Lew, and M. E. Keeling. 1996. Rev/RRE-independent Mason-Pfizer monkey virus-constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay. Virology 222:457-463.
33. Rizvi, T. A., K. A. Lew, E. C. Murphy, Jr., and R. D. Schmidt. 1996. Role of Mason-Pfizer monkey virus constitutive transport element in the propagation of MPMV vectors by genetic complementation using homologous/heterologous env genes. Virology 224:517-532.
34. Rizvi, T. A., R. D. Schmidt, and K. A. Lew. 1997. Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner. Virology 236:118-129.
35. Sonigo, P., C. S. Barker, E. Hunter, and S.-W. Hobson. 1986. Nucleotide sequences of Mason-Pfizer monkey virus: an immunosuppressive D-type retrovirus. Cell 45:375-385.
36. Sparger, E. E., B. L. Shacklett, L.-R. Gregg, P. A. Barry, N. C. Pedersen, J. H. Elder, and P. A. Luciw. 1992. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology 187:165-177.
37. Srinivasakumar, N., N. Chazal, C.-H. Maria, S. Prasad, M. L. Hammarskjold, and D. Rekosh. 1997. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines. J. Virol. 71:5841-5848.
38. Tada, H., J. Rappaport, M. Lashgari, S. Amini, F. Wong-Staal, and K. Khalili. 1990. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc. Natl. Acad. Sci. USA 87:3479-3483.
39. Takeuchi, Y., F. C. Cosset, P. J. Lachmann, H. Okada, R. A. Weiss, and M. K. L. Collins. 1994. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68:8001-8007.
40. Talbott, R. T., E. E. Sparger, K. M. Lovelace, W. M. Fitch, N. C. Pedersen, P. A. Luciw, and J. H. Elder. 1989. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86:5743-5747.
41. Tomonaga, K., T. Miyazawa, Y. Kawaguchi, M. Kohmoto, Y. Inoshima, and T. Mikami. 1994. Comparison of the Rev transactivation of feline immunodeficiency virus in feline and non-feline cell lines. J. Vet. Med. Sci. 56:199-201.
42. Wang, G., V. Slepushkin, J. Zabner, S. Keshavjee, J. C. Johnston, S. L. Sauter, D. J. Jolly, T. W. Dubensky, B. L. Davidson, and P. B. McCray. 1999. Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J. Clin. Investig. 104: 55-62.
43. White, S. M., M. Renda, N.-Y. Nam, E. Klimatcheva, Y. Zhu, J. Fisk, M. Halterman, B. Rimel, H. Federoff, S. Pandya, J. D. Rosenblatt, and V. Planelles. 1999. Lentivirus vectors using human and simian immunodeficiency virus elements. J. Virol. 73:2832-2840.
44. Yamamoto, J. K., H. Hansen, E. W. Ho, T. Y. Morishita, T. Okuda, T. R. Sawa, R. M. Nakamura, and N. C. Pedersen. 1989. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J. Am. Vet. Med. Assoc. 194:213-220.
45. Yang, S., and H. M. Temin. 1994. A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J. 13:713-726.
46. Yin, P. H., and W.-S. Hu. 1997. RNAs from genetically distinct retroviruses can copackage and exchange genetic information in vivo. J. Virol. 71:6237-6242.
47. Yin, P. H., V. K. Pathak, A. E. Rowan, R. J. Teufel II, and W.-S. Hu. 1997. Utilization of nonhomologous minus-strand DNA transfer to generate recombinant retroviruses. J. Virol. 71:2487-2494.